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A B S T R A C T
Aim: We aimed to evaluate the usefulness of left atrial (LA) mechanics and stiffness over global left
ventricular (LV) longitudinal strain (GLS) for risk stratiﬁcation in severe aortic stenosis (AS).
Methods: From a cohort of 89 prospective asymptomatic patients with severe AS and normal LV ejection
fraction, 82 (32 men, mean age 73  10 years) truly asymptomatic patients, scheduled after a negative
exercise echocardiogram,were enrolled. Forty age- and gender-matched prospective, asymptomatic subjects
served as controls. Predeﬁned end points were the occurrence of symptoms (dyspnea, angina, syncope), and
death during follow-up.
Results: At study entry, patients had: impaired LV GLS (p = 0.001), reduced LA reservoir (p < 0.001), high
LA stiffness (p < 0.001), and increased valvulo-arterial impedance (p < 0.001) compared to controls.
During follow-up [16  14.9 months (ranging from 1 month to 4.2 years)], 53 patients (64.6%) reached one
of the endpoints. Patients with events showed lower LV GLS (p > 0.001), lower LA reservoir (p < 0.001), and
greater LA stiffness (p < 0.001) than those asymptomatic. On univariate Cox regression analysis, LV GLS
(p < 0.001), LA reservoir (p < 0.001), and LA stiffness (p = 0.004) were strong predictors of adverse events.
Kaplan–Meier curves showed that event-free survival was signiﬁcantly higher in patients with a LV GLS
16.8% [p < 0.001; area under the curve (AUC) = 0.922; sensitivity = 86%, speciﬁcity = 80%], a LA reservoir
19.8% (p = 0.001; AUC = 0.860, sensitivity = 71%, speciﬁcity = 84%), and a LA stiffness<0.78 (p < 0.001; AUC
0.819, sensitivity 70%, speciﬁcity 89%). On multivariate analysis, only LV GLS remained signiﬁcantly
associated with patients’ prognosis (hazard ratio = 1.49, 95% CI = 1.11–2.01, p = 0.008).
Conclusions: In asymptomatic patients with severe AS, an efﬁcient cardiovascular system is based on an
effective atrial-ventricular interplay. LA function assessment is useful for early identiﬁcation of risk in
these patients. LV GLS however was conﬁrmed to be the best predictor of patients’ outcome.
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.* Corresponding author at: Aurora Cardiovascular Services, 2801W. Kinnickinnic
River Parkway, #840, Milwaukee, WI 53215, USA.
Tel.: +1 414 649 3909; fax: +1 414 649 3551.
E-mail address: publishing22@aurora.org (B. Khandheria).
http://dx.doi.org/10.1016/j.jjcc.2015.04.010
0914-5087/ 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsIntroduction
Aortic stenosis (AS) represents themost common valvular heart
disease in the general population [1]. The occurrence of symptoms
is crucial as a prognostic marker of this condition, which identiﬁes
patients that will require a short-term aortic valve replacement
[2,3]. In contrast, the management of asymptomatic patients,
particularly of those with preserved ejection fraction (EF), remainsreserved.
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pivotal role in risk stratiﬁcationofasymptomaticpatientswithsevere
AS, providing essential information on left ventricular (LV) function,
valve anatomy, and hemodynamics [4–7]. Furthermore, calcium
score of the aortic valve, an increased global LV afterload, as well as
subclinical LV longitudinaldysfunctionare currently gaining relevant
roles in the decision-making for asymptomatic patients [8–14].
Nonetheless, it has been clearly demonstrated that in AS,
particularly in hypertensive patients, beyond the well-known
consequences on ventricles and arteries, the chronically increased
afterload is also accompanied by a progressive left atrial (LA)
enlargement and dysfunction [15–17]. Moreover, an increased LA
volume appears as a marker of poor long-term prognosis in severe
AS [18].
However, the prognostic implication that an early detection of
LA functional impairment might have in these patients has not
been fully elucidated. Therefore, we sought to explore LA strain and
stiffness in a cohort of asymptomatic patients with severe AS and
preserved EF, with the aim to evaluate whether this additional
analysis of cardiac function may provide useful information in the
context of an accurate patients’ risk stratiﬁcation.
Methods
From June 2009 to January 2014, atrial mechanics were
prospectively evaluated in 89 consecutive asymptomatic patients
(36 men, mean age 76  11 years) with severe AS who were referred
to the echocardiographic laboratory for regular follow-up of their
valve disease. Severe AS was deﬁned as an aortic valve area (AVA)
<1 cm2 (or indexed AVA <0.6 cm2/m2), a trans-valvular peak
velocity 4 m/s on continuous wave Doppler, and a mean gradient
40 mmHg2. To better clarify symptom status, we used exercise
stress echocardiography, according tomodiﬁed Bruce protocol, which
has demonstrated an additive prognostic value over clinical ﬁndings,
resting echocardiography and exercise testing for unmasking
symptoms. An exercise echocardiogram was considered normal if
the patient remained asymptomatic (no angina, limiting dyspnea at
low workload, syncope, or near-syncope) during the test, with an
adequate increase in systolic blood pressure (>20 mmHg), absence of
complex ventricular arrhythmias and/or 2 mm horizontal or down
sloping ST segment depression, and/or wall motion alterations
[19,20]. Patients unable to perform exercise (n = 4) and those with
a positive response (n = 3) were excluded from the study. Thus, the
ﬁnal population consisted of 82 truly asymptomatic patients (32men,
mean age 73  10 years) with severe AS. No patient with paradoxical
(low ﬂow-low gradient) AS was enrolled.
Moreover, to exactly know the LA functional status in AS, mean
values of LA strain and stiffness from the patients’ cohort were
compared to those from a control group without AS, including
40 age-gender matched asymptomatic subjects (15men, mean age
73  10 years), undergoing standard echocardiogram for global
cardiovascular risk proﬁle evaluation, which were prospectively
and consecutively enrolled.
Both patients and controls all were in sinus rhythm. All had
normal LVEF (50%), no more than mild associated heart valve
disease, no kidney failure, no previous myocardial infarction, and
optimal image quality for endocardial border detection and
speckle tracking analysis.
At study entry, the following clinical data were collected: age,
gender, body surface area (BSA), history of hypercholesterolemia
(total cholesterol 190 mg/dl or patients receiving lipid-lowering
therapy), diabetes mellitus (fasting blood glucose 126 mg/dl on
two occasions or patients currently receiving oral hypoglycemic
medication or insulin), systemic arterial hypertension (blood
pressure 140/90 mmHg or patients receiving antihypertensive
treatment), and overweight (body mass index 25 kg/m2).The regional ethics committee approved the protocol, and all
subjects gave written informed consent.
Standard echocardiographic evaluation
Echocardiographic examinations were performed using a
VIVID-7 ultrasound machine (GE Vingmed Ultrasound, Horten,
Norway), equippedwith a phased-array transducer. M-mode, two-
dimensional, color Doppler, pulsed-wave, and continuous wave
Doppler data were stored on a dedicated workstation (EchoPAC,
version 8.0.0; GE Medical Systems), for ofﬂine analysis. The
measurements weremade for three cardiac cycles, and the average
value was calculated. The LV diameters, wall thickness, and
outﬂow tract (LVOT) diameter were measured according to the
recommendations of the American Society of Echocardiography
[21].
The transvalvular aortic velocity time integral, mean pressure
gradient, and peak aortic velocity were obtained using continuous
wave Doppler ultrasonography. The right parasternal view was
used whenever possible. The aortic valve area was determined
using the continuity equation method and indexed to the BSA,
using the Du Bois and Du Bois formula [22]. The stroke volume (SV)
was calculated using the Doppler method as follows: 0.785 
(LVOT diameter)2  LVOT velocity time integral. The LVEF was
derived using the biplane Simpson disk method [23]. The LV mass
was determined with the area-length method [21], and the mass
index was calculated as the LV mass/BSA (g/m2) ratio. The
diagnosis of LV hypertrophy was determined using a LV mass
index 102 g/m2 in men and 81 g/m2 in women [21]. A cut-off
value of 0.45 for the relative wall thickness was considered to
deﬁne a concentric remodeling [21]. The mitral ﬂow peak
velocities (E and A) and E/A ratio were measured using pulsed
wave Doppler. Furthermore, from stored color tissue Doppler
imaging loops, the value of E0 was obtained by averaging the peak
early-diastolic velocities calculated at the level of mitral annulus.
The E/E0 ratio was also included as an estimate of LV ﬁlling
pressure.
Systemic arterial pressure was measured using an arm cuff
sphygmomanometer before the Doppler echocardiographic exam-
ination. To estimate the global LV afterload, we calculated the
valvulo-arterial impedance (Zva; mmHg/ml/m2) as the sum of
systemic arterial pressure and the mean transvalvular pressure
gradient divided by the SV index [24]. Left atrial areas and volumes
were measured at end-LV systole, when the LA chamber is at its
largest size, using the biplanemethod of disks (modiﬁed Simpson’s
rule) in the apical four- and two-chamber view and average value
was obtained [21]. Mean areas and volumes of the LA were also
indexed to BSA to correct for body size variability. Care was taken
to exclude the pulmonary veins and LA appendage from the LA
tracing and the plane of the mitral annulus was used as inferior
border [21].
Speckle-tracking echocardiography
The analyses of both LA and LV mechanics were performed
ofﬂine by a single experienced and independent echocardiograph-
er from the recordings of two-dimensional (2D) gray-scale
imaging, using the EchoPAC semi-automated two-dimensional
strain software.
Three consecutive heart cycles were recorded and averaged,
using a frame rate of 60–80 frames/s.
LA strain and LA stiffness
Left atrial function was studied using 2D speckle-tracking
echocardiography performed from the apical four- and two-
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brief breath-hold andwith a stable electrocardiographic recording,
according to the recommendation for evaluating cardiac mechan-
ics [25]. Carewas taken to obtain true apical images using standard
anatomical landmarks to avoid foreshortening the LA, therefore
allowing a clear delineation of the atrial endocardial border. We
also avoided visualization of the LA appendage in the apical two-
chamber view in order to minimize its potential effect on LA strain
measurements. LA endocardial border was manually traced,
delineating a region of interest which consists of six segments
in apical four and six segments in two-chamber view [26]. After
segmental tracking, the quality analysis andmanual adjustment of
the region of interest, the longitudinal strain curves were
generated by the software for each atrial segment. Peak atrial
longitudinal strain (reservoir), measured at the end of LV systole,
was calculated by averaging values from all (12) LA segments
and by separately averaging values observed in the four- and
two-chamber views. Likewise, peak atrial contraction strain
(booster), obtained during LA systole, was measured as the
average of all segments and by separately averaging values from
the apical four- and two-chamber views. Automatically rejected
segments due to limited quality were not included in the overall
average values. From the same image, atrial strain rate was
calculated during conduit (early diastole) and booster pump
function (end-diastole) obtaining two negative diastolic strain
rate peaks (Sr1 and Sr2).
Finally, the E/E0 ratio was used in conjunction with LA reservoir
to derive LA stiffness calculated through the following formula:
E=E0
LA reservoir ð%Þ
This latter variable is a noninvasive dimensionless parameter that
was demonstrated to be correlated with invasive LA pressure [27].
LV mechanics
For the evaluation of LV global longitudinal strain (LVGLS) by
speckle tracking echocardiography, automated function imaging
was applied ofﬂine on apical long-axis, four-chamber and two-
chamber views, following an onscreen guided workﬂow. The
results were presented as a bull’s-eye display showing color-
coded and numeric values for peak systolic longitudinal strain.
For assessing global circumferential strain and radial strain, the
standard parasternal short-axis views at the basal, mid, and
apical levels with a frame rate of 70 frames per second were
acquired.
The relative global strains were obtained by calculating the
average strain derived by myocardial tracking from each short-
axis view. Finally, the LV rotations were derived from the apical
and basal short-axis images as the average angular displacement
of the six standard segments referring to the ventricular centroid,
frame by frame. LV twist was deﬁned as the net difference (in
degrees) of apical and basal rotations at the isochronal time
points. The opposite rotation after LV twist was deﬁned as LV
untwist and the time derivative of LV untwist was deﬁned as the
LV untwisting rate (8/s).
Follow-up
Follow-up information on AS course was obtained from
interviews with patients, their relatives, or their physicians every
six months. The predeﬁned endpoints for assessing the outcome
were the occurrence of symptoms (dyspnea, angina, syncope) or
death during follow-up. At the end of follow-up (16  14.9months,
ranging from 1 month to 4.2 years), patients were divided into twogroups according to the occurrence of events: group 0 (n = 29)
including all patientswho remain asymptomatic, and group 1 (n = 53)
consisted of those who experienced one or more events during
follow-up. We took the ﬁrst experienced event as an endpoint with
subsequent censoring.
Statistics
Continuous variables are presented as mean  standard devia-
tion (SD) and categorical variables are presented as percentages. The
unpaired Student’s t-test and the chi-square test were used for
comparisons of continuous and categorical variables, respectively.
Correlation between continuous variables was estimated using
Pearson’s coefﬁcient. The combined endpoint of the study included
the development of signiﬁcant symptoms (angina, dyspnea,
syncope) and cardiac death. Cox proportional hazards regression
analysis was used to identify independent predictors of events.
Receiver operating characteristic (ROC) curves were generated to
determine the performance of LV GLS, LA reservoir, and stiffness
for the prediction of cardiac events.
Cumulative overall and event-free survival rates were comput-
ed using the Kaplan–Meiermethod for predicting the occurrence of
events according to LV GLS, LA reservoir, and LA stiffness cut-off
values identiﬁed by ROC analysis. Groupswere compared using the
log-rank test. A two-tailed p-value <0.05 was considered signiﬁ-
cant.
Results
Aortic stenosis versus controls
Results from the ﬁrst analysis comparing demographic, clinical,
and echocardiographic characteristics of the patient population
with those of controls are represented in Table 1. Mean age of
patients was 73  10 years, 38% were male, and all presented with a
New York Heart Association class I. A history of hypertension was
reported by 27 patients (33%), dyslipidemia by 19 (23%), diabetes by 7
(8.5%); moreover 20 (24.3%) patients were smokers or former
smokers and only 6 (7.3%) were obese. In 22 patients (26.8%), more
than one risk factor was found. More than 50% of patients received
angiotensin-converting enzyme inhibitors, 35% angiotensin receptor
blockers, 7% beta-blockers only, and 12.2% calcium-channel blockers.
In both clinical and echocardiographic evaluation, the pathophysiol-
ogy of AS was degenerative-calciﬁc and all patients had tricuspid
aortic valves. In most patients, a concentric LV hypertrophy was
detected.
The analysis of LVmechanics revealed a signiﬁcant reduction of
longitudinal performance (p = 0.001), despite a normal EF, with
compensatory increase of circumferential strain (p = 0.04), apical
rotation (p < 0.001), twist (p < 0.001), and untwisting (p = 0.002).
Global ventricular afterload, expressed by Zva, was also increased
(p < 0.001; Table 1).
In regard to LA function, patients with severe AS showed a
signiﬁcant increase in LA volume (p < 0.001) associated with a
reduction in booster strain (p = 0.05) but mostly in reservoir strain
(p < 0.001; Table 2). There was also a decrease in the two diastolic
peaks of LA strain rate (p < 0.001) and an increase in atrial stiffness
(E/E0/LA strain) in patients compared with controls (p < 0.001,
Table 2).
The reduction in LA strain (reservoir) and the increase in LA
stiffness in AS patients were signiﬁcantly associated with more
severe valve disease (as expressed by indexed AVA), a low-ﬂow
state (as expressed by SV index), a higher Zva, increasing ﬁlling
pressure (noninvasively estimated by E/E0), lower LV longitudinal
function, and decreased untwisting forces of the ventricle, as
demonstrated by linear Pearson’s correlations (Table 3).
Table 1








Age (years) 7310 7110 0.28
Men 31 (37.8%) 15 (37.5%) 0.21
Body surface area (m2) 1.770.2 1.78 0.18 0.14




Hypertension 27 (33%) 13 (32.5%) 0.35
Diabetes mellitus 7 (8.5%) 3 (7.5%) 0.11
Smoker 20 (24.3%) 10 (25%) 0.37
Dyslipidemia 19 (23%) 9 (22.5%) 0.15
Obesity 6 (7.3%) 3 (7.5%) 0.24
ACE-inhibitors 45 (54.9%) 21 (52.5%) 0.30
ARBs 29 (35.4%) 14 (35%) 0.41
Beta-blockers 8 (9.7%) 5 (12.5%) 0.09
Calcium-channel-blockers 10 (12.2%) 5 (12.5%) 0.33
Left ventricle
Ejection fraction (%) 605 63.02.7 0.52
Stroke volume (ml/m2) 3712 485 0.003
Mass (g/m2) 12531 78.620.0 <0.001




E0 (m/s) 0.05 0.01 0.103 <0.001








Basal rotation 63 5.32.2 0.05
Apical rotation 157 7.5 <0.001
Twist 218 12.65.3 <0.001
Torsion (/cm) 3.12 1.90.7 <0.001
Untwisting (/s) 14044 10421 0.002
Aortic valve
Aortic valve area (cm2) 0.710.2 3.10.8 <0.001
Indexed aortic valve
area (cm2/m2)
0.4 0.1 1.74 0.2 <0.001
Peak gradient (mmHg) 85.524 253 <0.001
Mean gradient (mmHg) 5816 142.5 <0.001
Valvuloarterial impedance
(mmHg/ml/m2)
7.3 0.7 3.70.8 <0.001
ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker.
Table 3
Linear correlations of left atrial strain (reservoir) and stiffness.
Left atrial strain (%) Left atrial stiffness
r p r p
AVA (cm/m2) 0.30 0.02 0.40 0.006
Stroke volume (ml/m2) 0.34 0.01 0.45 0.004
Zva (ml/mmHg/m2) 0.53 0.001 0.63 <0.001
Left ventricle GLS (%) 0.65 <0.001 0.48 0.001
E/E0 0.45 0.002 – –
Untwisting (/s) 0.30 0.04 0.42 0.009
AVA, aortic valve area; GLS, global longitudinal strain; Zva, valvuloarterial
impedance.
Table 4
Demographic, clinical, and echocardiographic parameters of asymptomatic versus
symptomatic patients at the end of follow-up.
Variables Group 0 Group 1 p
No events With events
N=29 N=53
Demographics and clinics
Age (years) 75.88.3 71.411 0.05
Heart rate (beats/min) 7013 7111 0.42
Body surface area (m2) 1.78 0.2 1.750.2 0.57
Systolic blood pressure (mmHg) 12621 14021 0.02
Hypertension, n (%) 7 (24) 20 (38) 0.03
Dyslipidemia, n (%) 4 (14) 15 (28) 0.04
Diabetes, n (%) 2 (7) 5 (9.5) 0.32
Smoker, n (%) 2 (7) 4 (7.5) 0.50
Obesity, n (%) 1 (3) 5 (9.5) 0.038
Left ventricle
Ejection fraction (%) 60.64.5 595.2 0.19
Stroke volume (ml/m2) 44.311 33.711 0.001
Mass (g/m2) 11225 13231 0.007
E/A 0.7 0.3 0.8 0.3 0.35
Mitral deceleration time (ms) 20257 22269 0.21
E0 (m/s) 0.05 0.01 0.04 0.01 0.17
E/E0 143 186 0.002
Global longitudinal strain (%) 17.82.4 13.83 <0.001
Global radial strain (%) 5112 4011 0.03
Global circumferential strain (%) 235 214.6 0.21
Basal rotation 63 63 0.84
Apical rotation 14.36 15.87 0.42
Twist 206 218 0.56
Torsion (/cm) 3.53 31.2 0.45
Untwisting (/s) 12739 14545 0.18
Aortic valve
Aortic valve area (cm2) 0.74 0.2 0.680.2 0.35
Indexed aortic valve
area (cm2/m2)
0.42 0.1 0.380.1 0.27
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Follow-up datawere obtained in all patients. Average follow-up
duration was 16  14.9 months (ranging from 1month to 4.2 years).
During this time, 29 patients (35.4%) remained asymptomatic (group
0)whereas 53 (64.6%) reached one of the predeﬁned endpoints (group
1): 8 patients (15%) died (among those, 5 had a sudden death, 3 died
after a refractory acute pulmonary edema), 35 patients (66%)
developed dyspnea requiring hospitalization, 5 (9.4%) had angina,
and 5 (9.4%) syncope.Table 2







Left atrial volume (ml/m2) 4312 22.66.5 <0.001
Left atrial strain (reservoir) (%) 19.65 49.94 <0.001
Left atrial strain (booster) (%) 103 122 0.05
Early diastolic strain rate (SR1) (%/s) 0.70.4 1 0.2 <0.001
End diastolic strain rate (SR2) (%/s) 1.30.7 0.7 0.1 <0.001
Left atrial stiffness 0.90.1 0.17 0.1 <0.001Demographic, clinical, and echocardiographic variables of the
two groups are shown in Table 4. With regard to demographic
characteristics (age, sex category, BSA, heart rate) and risk factors,
in group 1 therewas a higher prevalence of hypertension (p = 0.03)
and dyslipidemia (p = 0.04) compared to group 0. In terms of
echocardiographic parameters, patients with events did not have a
more severe AS nor a lower EF, but they showed: lower indexed SVPeak gradient (mmHg) 81.726 8823 0.29
Mean Gradient (mmHg) 5412 6118 0.05
Zva (mmHg/ml/m2) 4.3 0.8 6.91.6 <0.001
Left atrium
Left atrial volume (ml/m2) 4211 4413 0.52
Left atrial strain (reservoir) (%) 23.46 17.64 <0.001
Left atrial strain (booster) (%) 9.42 103 0.46
Early diastolic strain
rate (SR1) (%/s)
0.7 0.5 0.650.3 0.66
End-diastolic strain
rate (SR2) (%/s)
 1.2 0.7 1.4 0.6 0.54
Atrial stiffness 0.7 0.2 1 0 <0.001
Zva, valvuloarterial impedance.
[(Fig._1)TD$FIG]
Fig. 1. Example of left atrial (LA) reservoir curves obtained by speckle tracking
echocardiography in (A) a control subject without aortic stenosis (AS), (B) a patient
with severe AS who remained asymptomatic during follow-up, and (C) a patient
with severe AS who developed syncope after 8 months of follow-up. A signiﬁcant
peak’s difference in these three LA reservoir curves is clearly evident.
M.C. Todaro et al. / Journal of Cardiology 67 (2016) 71–79 75(p = 0.001), higher LV mass (p = 0.007), increased Zva (p < 0.001),
and lower LV GLS (p < 0.001) compared to patients without events.
Any further difference between groups was found in other LV
mechanics parameters.
As for LA function, while there was any difference in LA volume,
booster function, and strain rate between the two groups, patients
who experienced events had lower values of LA reservoir
(p < 0.001) and increased stiffness (p < 0.001) if compared to
the asymptomatic group (Fig. 1).
Patients with major adverse clinical events (death) were, on
average, elderly (mean age = 82.4  2.5 years), with severe LV
hypertrophy (LVMI = 148  42 g/m2), a calciﬁed aortic valve with the
smallest area (AVA = 0.5  0.1 cm2), the highest peak gradient
(107  8 mmHg), high Zva (5.2  0.2 mmHg/ml/m2), low LV GLS
(11  2%), increased LA volume (69  27 ml), and low LA reservoir
(12  5%).
On univariate Cox regression analysis, LV GLS (hazard
ratio = 1.27; 95% CI = 1.17–1.39, p < 0.001), LA reservoir (hazard
ratio = 0.87; 95% CI = 0.81–0.94, p < 0.001), and LA stiffness
(hazard ratio = 2.6; 95% CI = 1.3–5.3, p = 0.004) were strong
predictors of adverse events during follow-up, as well as EF
(p = 0.015), LV mass index (p = 0.014), E/E0 (p = 0.001), SV index
(p = 0.004), and Zva (p < 0.001) (Table 5).
ROC curves showed that a cut-off of 16.8% (area under the
curve (AUC) = 0.92; sensitivity = 86%, speciﬁcity = 80%) for LV GLS,
of 19.8% (AUC = 0.86, sensitivity = 71%, speciﬁcity = 84%) for LA
reservoir, and of <0.78 (AUC = 0.81, sensitivity 70%, speciﬁcity
89%) for LA stiffness had the highest sensitivity and speciﬁcity for
predicting events occurrence (Fig. 2). Kaplan–Meier curves showed
that event-free survival was signiﬁcantly better in patients with
greater LV GLS (16.8%, p < 0.001), higher LA reservoir (19.8%,
p = 0.001), and lower LA stiffness (<0.78) (Fig. 3).
On multivariate analysis, only LV GLS remained a signiﬁcant
predictor of events occurrence (hazard ratio = 1.49, 95% CI = 1.11–
2.01, p = 0.008).
Discussion
Many studies have underlined the pivotal role of clinical and
echocardiographic variables for predicting outcome in asymptom-
atic patients with severe AS and preserved EF [4–12].
The extension of valve calciﬁcation [28,29], the severity of
obstruction, the progression of valve stenosis, LV hypertrophy [30],
and diastolic dysfunction [31], represent the strongest predictors
of death and major cardiac adverse events in these subjects.
Furthermore, exercise-testing response [7], aortic dilatation, otherTable 5
Univariate and multivariate Cox regression analysis of event-free survival.
Variable Univariate regression analysis
HR (95% C.I.) p-
Age 0.98 (0.96–1.0) 0
Hypertension 1.09 (0.40–2.9) 0
Dyslipidemia 0.67 (0.25–1.67) 0
LV EF 0.93 (0.88–0.98) 0
Mass 1.01 (1.00–1.029) 0
SV 0.95 (0.92–0.98) 0
Indexed AVA 0.07 (0.004–1.20) 0
Mean gradient 1.01 (0.99–1.02) 0
E/E0 1.12 (1.04–1.19) 0
LV GLS 1.27 (1.17–1.39) <0
Zva 1.49 (1.25–1.78) <0
LA reservoir 0.87 (0.81–0.94) <0
LA stiffness 2.6 (1.3–5.3) 0
AVA, aortic valve area; C.I., conﬁdence interval; EF, ejection fraction; GLS, global longitu
impedance.associated valve disease or coronary artery disease, and serum B-
type natriuretic peptide levels clearly contribute to the global
prognostic burden [6]. In the past, several papers were published
highlighting the importance of LV longitudinal function in risk
stratiﬁcation of asymptomatic patients with severe AS [8–12], andMultivariate regression analysis




.015 1.02 (0.94–1.10) 0.55
.014 0.99 (0.97–1.07) 0.59
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Fig. 2. Receiver operating characteristic (ROC) curves for left ventricular global
longitudinal strain (LV GLS) (A), left atrial (LA) reservoir (B), and LA stiffness (C). A
cut-off of 16.8% [areas under the curve (AUC) = 0.92; sensitivity = 86%,
speciﬁcity = 80%] for LV GLS (A), of 19.8% (AUC = 0.86, sensitivity = 71%,
speciﬁcity = 84%) for LA reservoir (B), and of <0.78 (AUC = 0.81, sensitivity 70%,
speciﬁcity 89%) for LA stiffness (C), have the higher sensitivity and speciﬁcity for
predicting events occurrence.
[(Fig._3)TD$FIG]
Fig. 3. Kaplan–Meier curves according to left ventricular global longitudinal strain
(LVGLS) (A), left atrial (LA) reservoir (B) and LA stiffness (C) identiﬁed cut-off values.
Event-free survival is signiﬁcantly better in patients with greater LV GLS (16.8%,
p < 0.001), higher LA reservoir (19.8%, p = 0.001), and lower LA stiffness (<0.78).
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increased LA volume has been introduced as an independent
predictor of prognosis in these patients [18]. However, the role of
atrial function as a contributor to the patients’ outcomes has been
poorly investigated to date [32]. With the present study, we
sought to attain a deeper insight into the risk stratiﬁcation of
asymptomatic AS patients by investigating whether atrial function
impairment could actually have any role.
Themain ﬁndings of the present study are: (1) in asymptomatic
patients with severe AS, besides the impairment of LVmechanics, a
reduction of atrial function, especially reservoir, and an increase in
atrial stiffness can also be detected; (2) the decrease of atrial
function is more pronounced in patients who develop symptoms
during follow-up and does not correlate with atrial chamber
enlargement; (3) event-free survival is signiﬁcantly higher in
patients with greater LA reservoir and lower LA stiffness; (4)
however, LV GLS appears to be the stronger independent predictor
of outcome.
From a pathophysiological point of view, AS is associated with a
chronic pressure overload that progressively generates higher LV
ﬁlling pressures to which the LA is directly exposed during diastole
[33]; for this reason LA enlargement has been considered the most
reliablenoninvasive surrogateof LVdiastolicdysfunctionand strong
predictor of prognosis [15,18]. However, intrinsic left atrial
myopathic disease, expressed by an early impairment of LA strain
during reservoir can precede or coexist with LA enlargement,
becoming an early marker of increased LV ﬁlling pressure [16,17];
thismaysuggest thatpatientswithasevere reductionofLAreservoir
are more likely to get symptoms, which occurred in our cohort.
LA function in all the phases of the cardiac cycle can be reliably
explored through speckle tracking echocardiography [26]. Particu-
larly, during ventricular systole, the LA acts as a reservoir collecting
blood from the pulmonary veins; thus stretching the atrial walls,
represented by positive strain and strain rate curves, and is greatly
inﬂuenced by both LA compliance and the mitral annular descent
from the cardiac base to the apex [34]. This is conﬁrmed by the
strong positive correlation between LA reservoir and LV longitu-
dinal performance, which was found in the present study and
previously identiﬁed by others [34].
There are other important factors thatmight affect the reservoir
function such as LA tissue properties, pulmonary venous ﬂow
volume, right atrial pressure, pericardial pressure, and intratho-
racic pressure and these factors are also inﬂuenced by each other.
Moreover, it has been demonstrated that LA reservoir (strain)
correlates strongly (inverse relation) with invasively determined
LV end-diastolic pressure [35], suggesting its usefulness for
assessing patients’ functional status.
In this regard, for a better estimate of atrial function during
ventricular systole, we introduced in the present investigation a
relatively new strain-derived parameter, the atrial stiffness which
showed a strong correlation with invasively measured LA and LV
ﬁlling pressure [27] andwas an indicator of reduced LA compliance,
increased ﬁbrosis [36], and atrial ﬁbrillation recurrence [37,38].
According to our results, an increased atrial stiffness might be
considered as an atrial-ventricular coupling index, in which the
progressive reduction of reservoir function and the concomitant
increase of LV ﬁlling pressure could denote a subclinical
impairment of both LV systolic and diastolic performance,
potentially able to predict a consistently worse prognostic burden
in still asymptomatic patients. Indeed, the reduction of LA
reservoir and the increase of LA stiffness signiﬁcantly correlated
with a more severe AS, a low-ﬂow state, a higher valvulo-arterial
impedance, increased ﬁlling pressure (E/E0), lower LV longitudinal
function, and decreased untwisting forces of the ventricle: this
conﬁrms the existence of a ‘‘functional link’’ between ventricle,
atrium, and arteries in AS.Nonetheless, GLS of the ventricle rather than LA reservoir or
stiffness remains the stronger predictor of prognosis in this cohort
of patients, as previously demonstrated [8]. This result may be
explained considering the primary involvement of the ventricle in
this valve disease, due to complex pathophysiological processes
(i.e. chronically increased afterload, increased ﬁbrosis, etc.), which
are independent of LA function. Moreover, it is important to
emphasize the key role of longitudinal deformation for LV systolic
performance and, consequently, for symptom occurrence. In
addition, we have to take into account that as LV GLS is the major
determinant of LA reservoir, it is reasonable that both LA reservoir
and stiffness (E/E0/LA reservoir) had lost independent values in
multivariate analysis.
On the other hand, data already available in the literature
demonstrated how LA and LV longitudinal dysfunction expressed
by low LA reservoir and reduced LV longitudinal strain are
intimately correlated with the pathophysiology of AS. It is
demonstrated that after transcatheter aortic valve implantation
or surgical aortic valve replacement, a signiﬁcant anatomical and
functional reverse remodeling of both LV and LA has been detected
in terms of reduced LV mass and improved LV and LA longitudinal
performance [39–42]. Moreover, a reduced LA strain has already
been associatedwith the severity of AS and has been identiﬁed as a
predictor of atrial ﬁbrillation recurrence after aortic valve
replacement [32].
However, to our knowledge, this is the ﬁrst study in which LA
strain and stiffness proved to be useful parameters for risk
stratiﬁcation of asymptomatic patients with severe AS.
Conclusions
In asymptomatic severe AS, the prognostic value of the
impairment of LV GLS appears to be indisputable. Nevertheless,
an efﬁcient cardiovascular system is based not only on an optimal
ventricular function but also on an effective atrial-ventricular
interplay. In this regard, atrial function, earlier than LA volume,
acts as a sensitive marker of outcome in these patients, thus its
evaluation could be included as part of echocardiographic risk
stratiﬁcation in AS.
Study limitations
Amain limitation of the present studywas that of the small size
of the patient population sample. Thus, these results need to be
conﬁrmed in a larger cohort. In addition, phasic changes in LA
volumes were not assessed. However, LA volume reﬂects LA
structural rather than functional changes. Moreover, its assess-
ment by echocardiography has some limitations. Unlike previous
studies, LA volume is unable to identify patients with poor
outcomes. This may be due to a less advanced stage of the disease
in our population in which the LA enlargement was not severe. On
the other hand, the absence of correlations between LA strain and
volume has been previously demonstrated [17]. Furthermore, use
of software for LA strain analysis that originated for evaluating LV
mechanics may be a technical limitation. However, previous
researchers successfully applied this tool for studying LA strain
with good results, particularly in the presence of high-quality 2D
images [26,34,36,40].
Despite the fact that in our study LA parameters demonstrated
to be associated with more severe AS and the recurrence of events,
LV GLS was superior to both LA strain and stiffness in predicting
patients’ prognosis; one of the most relevant limitations of LA
stiffness, calculated as E/E0/LA reservoir is that it is a surrogate
parameter, derived from amathematical assumption and therefore
is not as accurate as an invasive parameter. For this reason its
ability in predicting prognosis is less reliable.
M.C. Todaro et al. / Journal of Cardiology 67 (2016) 71–7978Another important limitation to our study is the lack of a
multimodality approach. Cardiac magnetic resonance is the best
imaging modality for detection of LA wall ﬁbrosis, which is the
landmark of LA structural remodeling and LA reservoir reduction.
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